Quick Answer
BIOREGENX, INC. reported Stockholders Equity of -$3.38 million for fiscal year 2024.
BIOREGENX, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$3.38M | -63.1% |
| 2023 | -$2.07M | +18.1% |
| 2022 | -$2.53M | -2901.1% |
| 2021 | -$84.2K | -147.4% |
| 2020 | $177.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.65M | -126.9% | +0.2% |
| June 30, 2025 | -$3.65M | -125.7% | -2.7% |
| March 31, 2025 | -$3.56M | -123.6% | -5.3% |
| December 31, 2024 | -$3.38M | -63.1% | -124.9% |
| September 30, 2024 | $13.56M | +584.7% | -4.6% |
| June 30, 2024 | $14.22M | +651.1% | -5.7% |
| March 31, 2024 | $15.09M | +724.6% | +828.3% |
| December 31, 2023 | -$2.07M | +18.1% | +26.0% |
- BIOREGENX, INC. showed a decrease of -63.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2024 period, BIOREGENX, INC.’s stockholders equity has declined by 2002.3% (from $177.6 thousand to -$3.38 million).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: